Ventana PD-L1 (SP263) Assay Reagent for Qualitative Detection of Programmed Death Ligand 1 (PD-L1) Protein by Immunohistochemistry in in vitro Diagnostics with Ventana BenchMark Automated Immunostainers

Ventana PD-L1 (SP263) Assay Reagent for Qualitative Detection of Programmed Death Ligand 1 (PD-L1) Protein by Immunohistochemistry in in vitro Diagnostics with Ventana BenchMark Automated Immunostainers

The Ventana PD-L1 (SP263) Assay reagent is designed for the qualitative detection of Programmed Death Ligand 1 (PD-L1) protein using immunohistochemical analysis in in vitro diagnostics.

This reagent is used with the automatic immunostainers from the Ventana BenchMark series.

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Ventana PD-L1 (SP263) Assay Reagent for Qualitative Detection of Programmed Death Ligand 1 (PD-L1) Protein by Immunohistochemistry in in vitro Diagnostics with Ventana BenchMark Automated Immunostainers, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.